MyMD Pharmaceuticals announced the appointment of Mitchell Glass, a member of the board of directors of the company, as president and chief medical officer. The company also announced the appointment of Stephen Friscia, a veteran investor, to the board of directors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYMD: